369656-41-7

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 18469-52-8 methyl 4-(aminomethyl)benzoate 
• 13750-81-7 N-methyl-2-imidazolcarboxaldehyde 
• 369656-38-2 4-{[(tert-butoxycarbonyl)(1H-imidazol-2-ylmethyl)amino]methyl}benzoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 369656-42-8 N-Boc-N-(1-methylimidazol-2-yl) aminomethyl benzoic acid 
• 864913-35-9 (4-hydroxymethylbenzyl)-(1-methyl-1H-imidazol-2-ylmethyl)-carbamic acid t-butyl ester 

Relevant academic research and scientific papers

BASIC AMINE COMPOUND AND USE THEREOF

Novel amine compounds which are represented by the following formula (1) and efficacious against diseases such as a viral infectious disease with HIV, rheumatism, and cancer metastasis; typically, A 1 and A 2 represent a hydrogen atom or a substitutable monocyclic or polycyclic heteroaromatic ring and W represents a substitutable benzene ring or any group represented by the following formula (10) or (11): where X represents O, CH 2 , C(=O), NR 11 , or CHR 35 and D represents a group represented by the following formula (6): where Q represents a single bond, NR 12 , or a group represented by the formula (13): and Y represents a group represented by the following formula (7) : where z represents a substitutable monocyclic or polycyclic aromatic ring; and B represents -NR 25 R 26 ; and R 1 to R 26 in the above formulae represent a hydrogen atom, an alkyl group, an alkenyl group, or an alkynyl group.

CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND

To provide novel nitrogen-containing compounds having antagonism to CXCR4 and remedies for disease, such as rheumatism, cancer metastasis, etc., based on the CXCR4 antagonism. Nitrogen-containing compounds represented by the following general formula and